Cargando…
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis
BACKGROUND: Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor microenvironment plays vital roles in metastasis. Modulating the tumor microenvironment via multiple pathways could efficien...
Autores principales: | Liu, Ying, Xie, Xingmei, Hou, Xuefeng, Shen, Junyi, Shi, Jiangpei, Chen, Haizhen, He, Yuanzhi, Wang, Zhi, Feng, Nianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260741/ https://www.ncbi.nlm.nih.gov/pubmed/32473632 http://dx.doi.org/10.1186/s12951-020-00638-x |
Ejemplares similares
-
Hybrid curcumin–phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer
por: Liu, Ying, et al.
Publicado: (2019) -
Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
por: Hou, Xiaoying, et al.
Publicado: (2018) -
Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability
por: Sahibzada, Muhammad Umar Khayam, et al.
Publicado: (2017) -
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
por: Bosch-Barrera, Joaquim, et al.
Publicado: (2016) -
Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction
por: Chen, Yi-He, et al.
Publicado: (2020)